Automated Monitoring of Asthma Using the BioSense System

Slides:



Advertisements
Similar presentations
Using ESSENCE IV An Overview Objectives Explain ESSENCE and its impact Define surveillance Define syndromic surveillance and its importance Demonstrate.
Advertisements

Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
1 Proprietary and Confidential 1 Identification of Potentially Avoidable Emergency Department Visits Using Claims Data APHA Session : Advances in.
TM 1 PHIN Conference Atlanta, GA August 27, 2008 Jeanne Tropper, MS, MPH 1 and Al Romanosky, MD, PhD 2 1 Division of Emergency Preparedness and Response.
Florida Emergency Department Collaborative June 8, 2011 Presented by: Howard Pitluk, MD, MPH, FACS, Vice President/Chief Medical Officer Margaret deHesse,
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
Implementing a Syndromic Surveillance System in Miami-Dade County Fermin Leguen, MD, MPH Chief Physician Director, Office of Epidemiology & Disease Control.
TM BioSense: Using Health Data for Early Event Detection and Situational Awareness DIMACS Working Group on BioSurveillance Data Monitoring and Information.
Asthma Prevalence in the United States National Center for Environmental Health Division of Environmental Hazards and Health Effects June 2014.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Aaron Fleischauer, PhD, MPH
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease.
1 INFLUENZA (AND OTHER RESPIRATORY VIRUS) SURVEILLANCE IN WISCONSIN Thomas Haupt M.S. Wisconsin Influenza Surveillance Coordinator.
Surveillance Overview Julia Gunn Boston Public Health Commission.
Slides last updated: October NSCLC is most often diagnosed at an advanced stage Many of the symptoms that do appear with more advanced disease can.
National Surveillance Estimates of Unintentional, Non-fire Related Carbon Monoxide Poisoning Jackie Clower, MPH Contractor, Air Pollution & Respiratory.
1 ESSENCE: Biosurveillance in Support of the DoD Health Mission.
H1N1 Influenza in Boston: Past, Present, and Future Media Briefing Boston Public Health Commission August 17, 2009.
IDENTIFYING FLU LIKE ILLNESS AGENDA  Sit Found Program  Data analysis – Results  Sit Found Program Recommendations  Monitoring influenza-like illness.
U.S. Influenza Surveillance Keiji Fukuda Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Enhancing Disease Surveillance with Spatial-temporal Results Patricia Araki, MPH County of Los Angeles – Department of Public Health Acute Communicable.
Successful Alerts and Responses: Real-time Monitoring of ED Chief Complaints and Investigation of Anomalies CDC Public Health Preparedness Conference February.
Traumatic Brain Injury in the United States Emergency Department Visits, Hospitalizations, and Deaths 1995–2001 National Center for Injury Prevention and.
1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.
Emergency Department Syndromic Surveillance (EDSS): A public health unit perspective alPHa Meeting Feb 1, 2007.
How do low-income limited English proficient adults use ambulatory health services when they have health insurance and access to interpreters? Elinor A.
Public Health Response to Traumatic Brain Injury
Slides last updated: March NSCLC is most often diagnosed at an advanced stage Many of the symptoms that do appear with more advanced disease can.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
North Carolina Community Care Networks (N3CN): Medical Home Access and Emergency Department (ED) Utilization May 2016.
The BioSense Influenza Module Craig Hales MD MPH, Roseanne English BS, Paul McMurray MDS, Michelle Podgornik MPH, Jerome Tokars MD MPH Centers for Disease.
Syndromic Surveillance Providing Kansas Information Our Mission: To protect and improve the health and environment of all Kansans.
Should Oklahoma be concerned about parasitic zoonoses? Jean Thompson, MPH 1 Lauri Smithee, MES, MS 1 Hélène Carabin, DVM, MSc, PhD 2 Oklahoma State Department.
Surveillance diagnoses 465.9URI 462Acute Pharyngitis 461.9Acute Sinusitis 466Acute Bronchitis 463Acute Tonsillitis Viral Infection 460Common Cold.
TELEHEALTH: IDENTIFYING GEOGRAPHIES WITH GREATEST POTENTIAL IMPACT
State Office of AIDS Update
Flu Update and Overview of Flu Surveillance in RI
Evaluating the Effectiveness of Using Syndromic Surveillance
National trends in nonfatal firearm-related injuries compared to deaths: Are firearm-related injury rates on the rise? J. Lee Annest, PhD Tad Haileyesus,
Emergency Department Visits in the Neonatal Period:
PEDIATRIC INFLUENZA IMMUNIZATION IN BALTIMORE CITY Anne Bailowitz, MD, MPH John Lamoureux, MPH Baltimore City Health Department March.
Marie P. Bresnahan, MPH, Mary M
CSTE Applied Epidemiology Fellow
Risk Factors for Suicidal Behaviors Among Los Alamos Youth
Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang.
Believed discrimination occurred because of their:
Data Describing the Opioid Addiction Issue in this Region
APHA, Washington, November, 2007
Amy Groom, MPH IHS Immunization Program Manager/CDC Field Assignee
Rise in Emergency Department Visits of Pediatric Patients for Renal Colic from John R. Allegra MD, PhD Morristown Memorial Residency in Emergency.
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
National STD Conference 2008
Bronx Community Health Dashboard: Influenza (Flu) Last Updated: 1/24/2018 See last slide for more information about this project.
What is “Syndromic” Surveillance?
One Health Early Warning Alert
* * Results Background Methods Conclusions
Representativeness of Emergency Department Data Reported to the BioSense System Patrick Minor, M.S.P.H., Roseanne English, B.S., Jerome Tokars, M.D, M.P.H.
Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C
SCHS and Health Statistics
Characteristics of Patients who Choose to Participate in a Comprehensive Medication Review (CMR) Program: Implication for Program Structure and Processes.
Public Health Surveillance
Pediatric Inactivated Influenza Vaccine Safety VAERS Reports for Trivalent Inactivated Influenza Vaccine (TIV) in Infants/Toddlers Ann McMahon, MD, MS.
SURVEILLANCE FOR WILDFIRE DISASTER
Note: for best viewing, please start this as a presentation
PNEUMONIA : A CASE-CONTROL STUDY.
Tom Savel, MD Lead – Grid Technologies Medical Officer NCPHI, CDC
Varicella Vaccine Efficacy Estimates
Automated Monitoring of Injuries Due to Falls Using the BioSense System Achintya N. Dey, MA1, Jerome I Tokars, MD MPH1, Peter Hicks, MPH2, Matthew Miller,
National Immunization Conference
Philip Huang, MD, MPH Director/ Health Authority
Presentation transcript:

Automated Monitoring of Asthma Using the BioSense System Keydra Phillips, MS1, Sule Mohammed, DVM, MS1, Gabriel Rainisch, MPH1, and Jerome Tokars, MD, MPH2 1SRA International, Inc, 2CDC August 27, 2008 National Center for Public Health Informatics Centers for Disease Control and Prevention PHIN Conference, Atlanta, GA Good after noon to all of you, I am Keydra Phillips, I am excited to share with you Disclaimer: The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention. 1

The BioSense System Serves as a national automated surveillance system Currently receives data from: 540+ civilian hospitals capturing about 11% of all U.S. emergency department (ED) visits 427 send patient chief complaints and 175 send final diagnoses Median times from patient visit to receipt of ED data at CDC are 8 hours for chief complaints and 5 days for diagnosis codes 355 Department of Defense (DoD) installations and 835 Veterans Affairs (VA) medical facilities 2

BioSense System Health Indicators which contains “493”, “asthma”, “wheezing”, “reactive airway disease”, “bronchospasm”, or “chest tight” which contains 493.XX Chief complaint Free text Final diagnosis ICD-9 Codes BioSense maps chief complaint and diagnosis data to 11 syndromes: Botulism-like Fever Gastrointestinal Respiratory Neurological Cutaneous lesion Lymphadenitis Hemorrhagic illness Rash Specific infection Severe illness or Death and 78 sub-syndromes Asthma Respiratory

Analysis Rationale The recent detection of several clusters pertaining to asthma spurred efforts to: Describe the ability of BioSense data to monitor asthma Understand what would improve system utility for automated monitoring of asthma Build collaborative relationships with asthma experts and local public health 4

Methods Retrospectively analyzed civilian hospital ED visits for asthma January 1 to December 31, 2007. Asthma = visits mapping to asthma subsyndrome Components of Analysis: Descriptive Rates by age group, time period, and city Associated chief complaints and final diagnoses Cluster identification and characterization Time series analysis Modified version of Early Aberration Reporting System (EARS) C-2 algorithm Recurrence interval threshold of 500 days City level unit of analysis 5

Descriptive Analysis

Results Of 12.4 million ED visits, 278,070 (2.2%) were asthma related 127,095 (46%) were for asthma chief complaint 114,881 (41%) were for an asthma diagnosis 36,149 (13%) had both These visits represented 239,315 patients (average 1.2 visits per patient) 7

Percent of ED Visits with Asthma, by Demographic Characteristics, Jan Percent of ED Visits with Asthma, by Demographic Characteristics, Jan. 1—Dec. 31, 2007 Age group (yrs) Asthma Chief Complaint visits n=163,189 Asthma Final Diagnosis visits n=150,975 0-3 23.4 10.8 4-11 18.2 15.3 12-19 9.8 11.8 20-49 33.7 44.6 > 50 14.9 17.5 Total 100.0 Gender Female 50.8 58.1 Male 49.2 41.9 8

Rates and Trends

Rate of ED Visits with Asthma, by Demographic Characteristics, Jan Rate of ED Visits with Asthma, by Demographic Characteristics, Jan. 1—Dec. 31, 2007 Age group (yrs) Rate of visits with asthma chief complaint Rate of visits with asthma final diagnosis 0-3 42.7 19.9 4-11 52.0 44.2 12-19 22.8 27.5 20-49 16.9 22.5 > 50 11.3 13.5 Gender Female 12.0 47.9 Male 14.2 43.1 Rates per 1,000 ED visits Chief complaint rates= Asthma CC visits/Total CC visits Final diagnosis rates= Asthma FD visits/Total FD visits 10

Rate of Asthma ED Visits by Age and Month, 2007 Chief Complaint Both graphs follow this same seasonal trend where rates are fairly constant from Jan to May for all age group Final Diagnosis 11

Rate of Asthma ED Visits in Selected U.S. Cities by Time Period, 2007 Chief Complaint Final Diagnosis

Associated Chief Complaints and Final Diagnoses

Most Frequent Subsyndromes Associated Subsyndromes for Visits with Asthma Chief Complaints, Jan. 1 – Dec. 31, 2007 Among the 163,189 visits with chief complaint of asthma: 53,526 (32.8%) also had chief complaints for dyspnea 34,433 (21.1%) also had chief complaint of cough Most Frequent Subsyndromes % Dyspnea 32.8 Cough 21.1 Chest pain 17.9 Fever 11.1 Upper respiratory infection 7.9 Nausea and vomiting Abdominal pain 6.3 Injury, NOS 3.9 Headache 3.8 Bronchitis and bronchilitis 2.2 This table displays the top 10 chief complaints that accompany a chief complaint of asthma These tables display that chief complaints better capture symptoms of asthma where as final diagnoses better capture perhaps co-morbidites.

Most Frequent Subsyndromes Associated Subsyndromes for Visits with Asthma Final Diagnoses Jan. 1 – Dec. 31, 2007 Among the 150,975 visits with final diagnosis of asthma: 22,948 (15.2%) also received final diagnosis for hypertension 19,627 (12.9%) also received final diagnosis of upper respiratory infection Most Frequent Subsyndromes % Hypertension 15.2 Upper respiratory infection 12.9 Dyspnea 9.7 Bronchitis and bronchilitis 8.8 Chest pain 8.2 Diabetes mellitus 8.0 Cough 6.1 Abdominal pain 5.5 Pneumonia / lung abscess 4.4

Cluster Identification and Characterization

Top 5 Asthma Clusters, Jan. 1 – Dec. 31, 2007 City # of Hospitals Type # of Cluster Days Peak Day Obs Exp Obs/Exp Stds San Diego, CA 6 Complaint 3 10/23/07 26 7 3.9 10 City A 15 1 09/16/07 46 3.0 8.4 City B 41 2 09/02/07 82 2.0 7.4 City C 25 Diagnosis 4 10/02/07 76 32 2.4 04/26/07 71 38 1.9 *Obs=observed count, Exp=expected count, Stds=standard deviations above expected

fires start; some evacuations ordered ED Visits by Chief Complaint and Final Diagnosis of Asthma –San Diego, CA, October 22-24, 2007 Physician diagnosis of asthma Chief complaint of asthma Days with significantly high (p<0.01)§ number of visits for asthma Witch Creek and Harris fires start; some evacuations ordered Wind changes from easterly to westerly Most evacuation orders retracted Fires contained Month and day No. of visits Sep Oct Nov 24 26 28 30 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 1 3 60 55 50 45 40 35 30 25 20 15 10 5 CDC. Monitoring Health Effects of Wildfires Using the BioSense System --- San Diego County, California, October 2007. MMWR 2008;57:27--741-747 .

Asthma Cluster, City A September 16, 2007

Asthma Cluster, City B September 1-2, 2007

Asthma Cluster, City C October 1-4, 2007

Asthma Cluster, City C April 23-26, 2007

Summary Using data in the BioSense system, we were able to effectively identify secular trends in asthma ED visits; rates decreased during the summer months and increased during the fall season. Asthma ED visit rates were higher for final diagnoses and highest among the 4-11 age group. The most frequent co-morbidities were dyspnea, chest pain, and cough for chief complaints visits, and hypertension, dyspnea, upper respiratory infection for final diagnosis visits. Seasonal trends, demographic trends, and geographic clusters found in BioSense data are confirmed in other data sources and asthma studies.

Conclusions Asthma is one of the limited number of diseases that can be effectively monitored using chief complaint and final diagnosis data. The potential utility of the BioSense system for automated monitoring of asthma includes the timeliness of the data, variety of data types, and the wide national coverage. The results of this analysis suggest that BioSense may be an important and timely source of information on asthma that could be used to track morbidity and inform public health interventions for leveraging prevention efforts. 24

Next Steps Engage subject matter experts to study the utility of BioSense in supplementing current asthma surveillance and research efforts. Identify correlations between atmospheric trace elements and asthma seasonal trends. Use SatScan software to perform spatial data analyses for each month at city, multistate, or regional levels.

Acknowledgment Hospital Emergency Dept Data Sources Alegent Health Aurora Health Care Corporate Office Banner Health Baylor Health Care System BJC Healthcare CHRISTUS Health Cook Childrens Health Care System Cook County Bureau of Health Cook County Dept of Public Health Gwinnett Health System Indiana State Department of Health Individual Hospitals MedStar Health Methodist Healthcare Michigan Dept of Community Health Missouri Dept of Health/Senior Services Mount Carmel Health System North Carolina (NC Detect) Ohio Department of Health Saint Luke's Health System Sentara Healthcare Sharp HealthCare Sierra Providence Health Network Tarrant County Advanced Practice Center Tenet Healthcare Corporation U of California San Diego Healthcare Beth Israel Deaconess Medical Center Children's Hospital Boston Children's Hospital Los Angeles Denver Health and Hospital Authority Johns Hopkins Hospital and Health System Oregon Health Sciences University Thomas Jefferson University Hospital University Medical Center Las Vegas

Thank You www.cdc.gov/biosense BioSenseHelp@CDC.GOV 27